nuwellis.com (NUWE) Market Cap to Net Assets Ratio

Nuwellis Inc - graphic logo of issuer NUWE

Chronic cash shortages and slow technology adoption negate the predictability of Nuwellis, Inc. (NUWE) FCF. The market-to-book ratio on this GURU.Markets platform chart demonstrates the current trend, where the -0.18 mark records this metric. Low commercial deployment rates inflate costs, while the implementation of plastic recycling and energy saving at plants aligns with current ESG standards.

Nuwellis Corp (NUWE) - Market Value to Book Value from 07/04/2022 to 10/30/2026
Manufactured product of Nuwellis Inc

For Nuwellis, Inc., which is expanding its clinic network through the supply of Aquadex systems, this indicator serves as a tool for assessing capital quality. The metric is calculated as the ratio of the company's market value to the value of its net assets. By analyzing the current market capitalization relative to the book value, an investor determines the extent of the premium paid for the business. High values signal inflated market expectations, while a low coefficient indicates that the company's tangible assets are undervalued.

Competing companies

DXCM: Market Capitalization to Book Value Ratio|Market-to-Book Ratio penumbrainc.com (PEN)|Market Cap to Net Assets Ratio NOVT|HAE (Haemonetics Corp) - Market Cap to Book Value Multiple|Market Capitalization to Book Value Ratio INSP|PRCT (Procept) - Market Value to Book Value|Market Capitalization to Book Value Ratio CNMD (CONMED Corporation)|pulsebiosciences.com (PLSE) - Market-to-Book Ratio|INMD - Market Value to Book Value Ratio|Market Value to Book Value PMI (Picard Medical Corp)|SRDX: Market Capitalization to Book Value Ratio|Senseonics Holdings, Inc. (SENS) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio NeuroPace, Inc.|Tactile Systems Technology Inc. - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio SNWV|OM - Market-to-Book Ratio|Electromed - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio LENSAR Inc LNSR|RCEL: Market Cap to Net Assets Ratio|Profound Medical Corp. - Market Cap to Book Value Multiple|BDMD: Market Capitalization to Book Value Ratio|EDAP - Market Capitalization to Book Value|APYX (Apyx Medical Corp) - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio IceCure Medical, Ltd. (ICCM)|Market Cap to Net Assets Ratio LUNG (Pulmonx Corporation)|TELA (telabio.com) - Market Value to Book Value|Market Value to Book Value Ratio CytoSorbents Corporation CTSO|SRTS - Market Cap to Net Assets Ratio|Zynex Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio electroCore, Inc.|RBOT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio IINN|ICU (SeaStar Medical) - Market Capitalization to Book Value Ratio|IRIDEX Corp. (IRIX) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio INBS|Market Cap to Net Assets Ratio beyondair.net XAIR|Market Capitalization to Book Value Ratio PFSA (Profusa Inc)|Market Capitalization to Book Value Ratio STRATA Skin Sciences Inc. SSKN|GCTK - Market Value to Book Value Ratio|NAOV: Market Value to Book Value Ratio|VERO (Venus Concept Corp) - Market Cap to Net Assets Ratio|Aethlon Medical Corp - Market Value to Book Value|ASXC (Asensus Surgical Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio avinger.com AVGR|Market Value to Book Value Ratio biosig.com (BSGM)|Cutera Inc. (CUTR) - Market Value to Equity Ratio|Know Labs Corp - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Nevro Corp. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value ReShape Lifesciences RSLS|Silk Road Medical (SILK) - Market Value to Book Value Ratio